Timothy Moore
Chief Tech/Sci/R&D Officer at ALLOGENE THERAPEUTICS, INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Timothy L.
Moore is currently serving as the Independent Director at BioLife Solutions, Inc. since 2022 and at Cerus Corp.
since 2018.
He is also a Member of the International Society for Pharmaceutical Engineering and the Parenteral Drug Association.
In 2023, he will assume the role of Chief Technical Officer & Executive Vice President at Allogene Therapeutics, Inc. Previously, Mr. Moore held positions as the Independent Non-Executive Director at Cognate BioServices, Inc., Director at Fusionkite, Senior Vice President-Global Supply Chain at Genentech, Inc. from 2004 to 2010, Vice President-Operations at Aventis Behring from 2000 to 2004, and Vice President-Operations at CSL Behring LLC.
He also served as the Executive Vice President-Technical Operations at Kite Pharma, Inc. from 2016 to 2019 and as the President, Chief Operating & Technical Officer at PACT Pharma, Inc. Mr. Moore's education includes a graduate degree from Northwestern University and an undergraduate degree from The University of Tulsa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 21/04/2024 | 265,459 ( 0.16% ) | 1 M $ | 30/03/2024 | |
BIOLIFE SOLUTIONS, INC.
0.07% | 07/03/2024 | 29,897 ( 0.07% ) | 554 589 $ | 30/03/2024 |
CERUS CORPORATION
0.06% | 06/06/2023 | 105,073 ( 0.06% ) | 198 588 $ | 30/03/2024 |
Timothy Moore active positions
| Companies | Position | Start |
|---|---|---|
| CERUS CORPORATION | Director/Board Member | 04/09/2018 |
| BIOLIFE SOLUTIONS, INC. | Director/Board Member | 31/08/2022 |
| ALLOGENE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2023 |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
| Parenteral Drug Association | Corporate Officer/Principal | - |
Former positions of Timothy Moore
| Companies | Position | End |
|---|---|---|
| INSTIL BIO, INC. | Chief Operating Officer | 07/12/2022 |
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - |
| Aventis Behring | Corporate Officer/Principal | 30/06/2004 |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Director/Board Member | - |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Training of Timothy Moore
| Northwestern University | Graduate Degree |
| The University of Tulsa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIOLIFE SOLUTIONS, INC. | Health Technology |
| CERUS CORPORATION | Health Technology |
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| INSTIL BIO, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Aventis Behring | Health Technology |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Health Technology |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
| Parenteral Drug Association | |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
| Fusionkite |
- Stock Market
- Insiders
- Timothy Moore
